China, Emerging Markets To Lead Record $1 Trillion Drug Market In 2014
This article was originally published in PharmAsia News
With China in the lead, the emerging markets are expected to play a major role next year in building a $1 trillion global market for prescribed medicines, according to the IMS Institute for Healthcare Informatics.
You may also be interested in...
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.